DHG Pharmaceutical JSC (HOSE:DHG)
94,400
-600 (-0.63%)
At close: May 22, 2026
DHG Pharmaceutical JSC Revenue
DHG Pharmaceutical JSC had revenue of 1.20T VND in the quarter ending March 31, 2026, with 0.30% growth. This brings the company's revenue in the last twelve months to 5.27T, up 9.33% year-over-year. In the year 2025, DHG Pharmaceutical JSC had annual revenue of 5.27T with 7.82% growth.
Revenue (ttm)
5.27T
Revenue Growth
+9.33%
P/S Ratio
2.34
Revenue / Employee
1.88B
Employees
2,806
Market Cap
12.34T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.27T | 382.10B | 7.82% |
| Dec 31, 2024 | 4.88T | -130.53B | -2.60% |
| Dec 31, 2023 | 5.02T | 339.38B | 7.26% |
| Dec 31, 2022 | 4.68T | 672.85B | 16.81% |
| Dec 31, 2021 | 4.00T | 247.55B | 6.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Traphaco JSC | 2.74T |
| Imexpharm | 2.39T |
| Cuu Long Pharmaceutical JSC | 1.31T |
| OPC Pharmaceutical JSC | 1.13T |
| Vidipha Central Pharmaceutical JSC | 971.25B |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| American Vietnamese Biotech Incorporation | 154.07B |